About Microneedle Patches
A Microneedle Patches is an array/patch for transdermal drug delivery. Microneedles are tiny tools used to convey vaccines or different medications across different obstructions, while the transdermal application is the most mainstream utilization of microneedles, intraocular and intracochlear microneedle drug conveyance frameworks are arising. Microneedles are built through different techniques typically including photolithographic measures or micro molding. These strategies include scratching minute construction into gum or silicon to project microneedles. Microneedles are produced using an assortment of materials going from silicon, titanium, tempered steel, and polymers. Some microneedles are made of a medication to be conveyed to the body however are molded into a needle so they will enter the skin.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The leading organizations in the market to avail competitive advantage makes new launches of the microneedle patch under their own brand. The companies know that different players are coming into the market and they are making the collaboration with the other leading players and develop new systems. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Microneedle Patches market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Skyn ICELAND (United States), Sparsha Pharma (India), Raphas (Korea), Micropoint Technologies (Singapore), Bela LAB (United States), Nissha Co. (Japan), CosMED Pharmaceutica (Japan), Micron Biomedical (United States) and Win Coat Corporation (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Peace Out (United States) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Microneedle Patches market by Type (Dissolving Type and Insoluble Type), Application (Medical and Cosmetics) and Region.
On the basis of geography, the market of Microneedle Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Increase in adoption in a number of safety issues that are emerging, which have short and long term implications for clinicians, patients and Increase in use of microneedle patches for the prevalence of cardiovascular diseases and stroke globally
Market Growth Drivers:
Growing research and development initiatives and Growing demand for a safer alternative to conventional hypodermic injections
Challenges:
High cost of research and development and Development of favorable government policies regarding health care infrastructure and awareness of contagious diseases.
Restraints:
Drug degradation and poor absorption and Local irritation and variability in absorption
Opportunities:
Continuous research and development of new framework regarding microneedle patches in emerging countries and Formulation of standard rules and regulations for safety measures
Market Leaders and their expansionary development strategies
In September 2019, LOUGHBOROUGH, England Nemaura Pharma Limited, a UK-based Biopharmaceutical Company specializing in transdermal and injectable drug delivery systems announced a strategic collaboration with Sparsha USA. Sparsha is based in California and specializes in the development and commercial manufacture of transdermal patches and oral thin films. Under the terms of the strategic collaboration, Nemaura will develop transdermal therapeutic systems at its facilities in Loughborough UK, up to pilot clinical manufacture, for global Pharmaceutical companies as well as internally funded programs.
In May 2019, Nissha Co., Ltd. has begun selling its own brand cosmetic microneedle patch SHOT MODE series. Using its core technologies of high-precision molding and laminating, Nissha has succeeded in developing hyaluronic acid-based microneedles. This is the first time that Nissha has started selling the cosmetic microneedle patches under its own brand.
Key Target Audience
Skincare Hospitals, Industrial Associations, Government Regulatory Bodies, Government Research Organizations and Private Research Organizations
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.